ArticleCancer management and research2020

Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy.

Guoxin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.